Skip to main content

Table 1 Study Population Characteristics

From: Effect of ultrafiltration during hemodialysis on hepatic and total-body water: an observational study

Age (yrs) 58.6 ± 18
Gender (M/F) 13/1
BMI (g/m2) 23.8 ± 2.6
Diabetes (Y/N) 5/9
Known CAD (Y/N) 5/9
Aetiology of ESRF (DM/HTN/Other) 5/3/6
ACEi/ARB (Y/N) 5/9
Calcium channel blocker (Y/N) 10/4
Beta blocker (Y/N) 10/4
Alpha blocker (Y/N) 2/12
Diuretic (Y/N) 6/8
Use of ESA (Y/N) 10/4
Time on dialysis (months) 9 (4–172)
Time receiving HD (months) 6 (1–172)
Previous transplant (Y/N) 4/10
Current HD access (CVC/AVF) 12/2
Hemoglobin (g/L) 107 ± 13
Haematocrit (L/L) 0.324 ± 0.04
Sodium (mmol/L) 136 ± 3.9
Albumin (g/L) 38.5 ± 6.2
Bilirubin (μmol/L) 4.19 ± 1.2
  1. M male, F female, Y yes, N no, CAD coronary artery disease, ESRF end-stage renal failure, HTN hypertension, DM diabetes, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, ESA erythopoeisis-stimulating agent, CVC central venous catheter, AVF arteriovenous fistula. All blood results represent pre-dialysis values